As Sr. Vice President of Market Access, Stephen helps design integrated market strategies for novel technologies that cover the entire product life span. Prior to Avania, he founded Hull Associates, a specialized global reimbursement strategy firm working in all major therapeutic areas. He has also served as a committee chair for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and has an advanced degree in health policy from the Johns Hopkins Bloomberg School of Public Health and a bachelor’s degree in international relations and French from Colgate University.

Back to Team

Your product is important, and your trial deserves the team that has what it takes. It takes knowledge. It takes passion. It takes commitment. It Takes Avania.

Let’s Talk